Showing 25 of 25597 results
Number of displayed results:
- DNase-seq in activated naive CD4-positive, alpha-beta T cellHomo sapiens activated naive CD4-positive, alpha-beta T cell male adult (43 years) treated with 10 ng/mL Interleukin-2 for 5 days, anti-CD3 and anti-CD28 coated beads for 7 daysLab: John Stamatoyannopoulos, UWProject: ENCODETreatments: 10 ng/mL Interleukin-2 (UniProtKB:P60568) for 5 days, anti-CD3 and anti-CD28 coated beads for 7 days
- Hi-C in HCT116Homo sapiens HCT116 treated with 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hoursLab: Erez Aiden, BaylorProject: ENCODETreatment: 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hours
- Hi-C in HCT116Homo sapiens HCT116 treated with 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hoursLab: Erez Aiden, BaylorProject: ENCODETreatment: 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hours
- Hi-C in HCT116Homo sapiens HCT116 treated with 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hoursLab: Erez Aiden, BaylorProject: ENCODETreatment: 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hours
- Hi-C in HCT116Homo sapiens HCT116 treated with 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hoursLab: Erez Aiden, BaylorProject: ENCODETreatment: 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hours
- TF ChIP-seq in HepG2Homo sapiens HepG2 expressing RNAi targeting H. sapiens FOXA3
- Control ChIP-seq in HepG2Homo sapiens HepG2